Bovine Leukosis: Welfare Implications of a Widespread Cattle Virus

Bovine leukosis virus infects most cattle herds globally — while most infections are subclinical, the minority developing lymphoma face significant welfare suffering.

Key Facts

• Bovine leukemia virus (BLV) infects cattle worldwide, with up to 84% seroprevalence in some US herds
• The vast majority of infected cattle remain subclinical with no welfare impact
• Approximately 1-5% of infected cattle develop lymphoma causing visible welfare harm
• Lymphoma signs include weight loss, enlarged lymph nodes, exophthalmia, and organ failure
• No treatment is available — welfare management focuses on early identification and humane slaughter

Welfare Considerations

Bovine leukosis welfare concerns are concentrated in the small proportion of infected cattle that develop lymphoma. These animals experience progressive deterioration from tumor growth in lymph nodes, abomasum, heart, uterus, and spinal cord, causing pain, dysfunction, and decline. Exophthalmia (eye protrusion from retrobulbar tumor) is a visible welfare indicator. Uterine lymphoma causes reproductive failure and calving difficulties. Once lymphoma is diagnosed, there is no effective treatment — welfare management requires prompt assessment of individual quality of life and humane slaughter before severe suffering occurs. Herd-level BLV control through test-and-cull programs reduces the proportion of cattle progressing to lymphoma over time.

What You Can Do

• Implement test-and-management programs to reduce BLV prevalence in your herd over time
• Monitor BLV-positive cattle for early lymphoma signs: weight loss, enlarged nodes, eye changes
• Establish clear welfare endpoint criteria for cattle developing lymphoma — early humane slaughter prevents suffering
• Use hygienic practices during dehorning, tattooing, and blood testing to prevent iatrogenic BLV spread
• Consult your veterinarian about BLV test-and-segregation strategies for reducing herd prevalence